HCPCS codes

22720 HCPCS codes with hospital pricing data in the network.

• HCPCS Q0162 — Oral ondansetron tablet or liquidAI (1703 hospitals, 48,445–69,550 samples)
• HCPCS J2997 — Alteplase injectionAI (2414 hospitals, 13,705–66,454 samples)
• HCPCS C1771 — Retropubic tension-free vaginal tape sling deviceAI (1762 hospitals, 7,861–65,821 samples)
• HCPCS G0009 — Pneumococcal vaccine administrationAI (2194 hospitals, 48,361–65,317 samples)
• HCPCS J1250 — Injection of dobutamine, 250 mgAI (2299 hospitals, 49,412–63,992 samples)
• HCPCS J1163 — Diltiazem 25 mg injectionAI (1678 hospitals, 53,540–62,900 samples)
• HCPCS J2785 — Regadenoson injection, 0.4 mgAI (2236 hospitals, 37,956–62,796 samples)
• HCPCS Q5118 — Zirabev bevacizumab biosimilar cancer drug injectionAI (1742 hospitals, 61,029–62,217 samples)
• HCPCS J3360 — Diazepam injection, 5 mg/mLAI (2367 hospitals, 15,832–62,074 samples)
• HCPCS J9181 — Etoposide injection, 10 mgAI (2065 hospitals, 58,106–61,508 samples)
• HCPCS G0239 — Group respiratory therapy sessionAI (1892 hospitals, 54,956–60,131 samples)
• HCPCS J0360 — Hydralazine injection, 20 mg per mLAI (2372 hospitals, 13,800–59,673 samples)
• HCPCS C1817 — Heart septal occluder device, 27mmAI (1521 hospitals, 6,266–58,835 samples)
• HCPCS L8613 — Stapedotomy ear implant pistonAI (1592 hospitals, 6,280–58,192 samples)
• HCPCS C9145 — Injection of aprepitant (Aponvie), per 1 mgAI (1089 hospitals, 55,791–58,149 samples)
• HCPCS Q5115 — Rituximab-abbs (Truxima) biosimilar injection, per 10 mgAI (2004 hospitals, 53,395–57,544 samples)
• HCPCS J3374 — Vancomycin 750 mg injectionAI (1374 hospitals, 51,400–57,466 samples)
• HCPCS J9306 — Pertuzumab injection, per 1 mgAI (1881 hospitals, 55,582–56,779 samples)
• HCPCS J7510 — Prednisolone sodium phosphate oral solutionAI (2138 hospitals, 11,071–56,350 samples)
• HCPCS J2002 — Intravenous lidocaine infusion in dextrose solutionAI (1984 hospitals, 55,431–56,295 samples)
• HCPCS P9046 — Albumin (human) 25% infusionAI (1404 hospitals, 55,570–56,218 samples)
• HCPCS J7168 — Kcentra injection, 1 international unitAI (2128 hospitals, 53,502–55,383 samples)
• HCPCS J7192 — Factor VIII clotting protein, per unitAI (1700 hospitals, 54,183–54,714 samples)
• HCPCS J0171 — Epinephrine injection, 0.1 mgAI (1474 hospitals, 15,480–54,279 samples)
• HCPCS J0290 — Ampicillin sodium injection, 2 gramAI (2390 hospitals, 15,902–53,963 samples)
• HCPCS J0692 — Cefepime injection, 2 gram IVAI (2355 hospitals, 15,399–53,802 samples)
• HCPCS L3908 — Ready-made wrist splint, cock-up styleAI (1953 hospitals, 6,912–52,713 samples)
• HCPCS G0121 — Colonoscopy for colorectal cancer screening, not high riskAI (1996 hospitals, 27,098–52,685 samples)
• HCPCS J1940 — Furosemide 10 mg/mL injectionAI (1254 hospitals, 6,066–52,254 samples)
• HCPCS J3376 — Vancomycin hydrochloride injection, 10 mgAI (515 hospitals, 51,542–52,055 samples)
• HCPCS C1766 — Introducer sheath for heart proceduresAI (1669 hospitals, 8,905–52,024 samples)
• HCPCS C1721 — Dual-chamber implantable defibrillator, Cobalt modelAI (1744 hospitals, 5,247–51,696 samples)
• HCPCS J9075 — Cyclophosphamide injection, 5 mgAI (1929 hospitals, 44,758–51,607 samples)
• HCPCS Q9957 — Perflutren lipid microspheres ultrasound contrast injectionAI (1967 hospitals, 26,472–51,285 samples)
• HCPCS A9579 — Gadolinium MRI contrast agent, 15 mLAI (1823 hospitals, 30,319–50,830 samples)
• HCPCS J0702 — Betamethasone sodium phosphate and acetate injectionAI (2307 hospitals, 21,030–50,298 samples)
• HCPCS B4087 — Gastrostomy feeding tube, 14 French, 1.5 cmAI (1129 hospitals, 5,142–49,773 samples)
• HCPCS G0108 — Diabetes self-management training, individual session (30 minutes)AI (2034 hospitals, 31,705–49,210 samples)
• HCPCS J3420 — Vitamin B12 injection, 1000 mcg per mLAI (2412 hospitals, 28,928–49,205 samples)
• HCPCS A4217 — Sterile water or saline, 500 mlAI (1018 hospitals, 46,283–49,091 samples)
• HCPCS J3380 — Vedolizumab intravenous injection, per 1 mgAI (2007 hospitals, 44,811–48,933 samples)
• HCPCS C1777 — Defibrillator lead wire, bipolar, 65 cmAI (1693 hospitals, 5,067–48,690 samples)
• HCPCS C1722 — Fortify Assura VR implantable defibrillator generatorAI (1757 hospitals, 4,959–48,411 samples)
• HCPCS C1759 — 10 French SNDSTAR catheterAI (1599 hospitals, 8,855–47,843 samples)
• HCPCS J9055 — Cetuximab injection, per 10 mgAI (1924 hospitals, 46,532–47,693 samples)
• HCPCS J1745 — Infliximab, 10 mg doseAI (2161 hospitals, 42,338–47,288 samples)
• HCPCS J2305 — Injection, nitroglycerin, 5 mgAI (2139 hospitals, 31,754–47,288 samples)
• HCPCS J9261 — Nelarabine injection, 50 mgAI (1449 hospitals, 46,809–47,097 samples)
• HCPCS C2618 — Cryoablation probe for nerve blockAI (1721 hospitals, 6,691–47,002 samples)
• HCPCS Q3014 — Telehealth originating site facility feeAI (1773 hospitals, 26,931–46,200 samples)